Latest filing published 04 Dec 2024 for BeiGene, Ltd., €3.4B.
Filing timeline
BuySaleInsider track record
HHLR Advisors, Ltd.: trading record in brief
This profile gathers the share dealings of HHLR Advisors, Ltd. in BeOne Medicines Ltd. We count 10 filings; the first trade dates from 22 August 2022 and the latest from 2 December 2024.
No open-market purchase appears, only 9 sales worth €4.1B. In 2024 alone, the filings show no purchases and 1 sale.
The newest entry dates from 4 December 2024: an open-market sale of €3.4B, in BeOne Medicines Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to HHLR Advisors, Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,842,500 shares@ US$200.0090.5% of flowOrdinary SharesSEC:0000902664-24-006828:0
- 611,000 shares@ US$211.45223.2% of flowOrdinary SharesSEC:0000902664-23-003603:0
- 1,163,825 shares@ US$218.14436.3% of flowOrdinary SharesSEC:0000902664-23-003537:0
- 7,800 shares0Ordinary SharesSEC:0000902664-22-004100:0
4 of 4 declarations
